Abstract
There are many viruses that cause hepatitis. In this chapter we discuss three of them: hepatitis A (jaundice), hepatitis B (serum hepatitis), and hepatitis C. Hepatitis A is an acute infection, whereas hepatitis B and C are blood-borne diseases and cause chronic infections and eventually cirrhosis of the liver and liver cancer. Outbreaks of hepatitis A were once very common in most of the world, since it was spread by unsanitary conditions Hepatitis A disrupted military campaigns throughout the ages. A vaccine is now available, and hepatitis A has almost disappeared from the developed world. A recombinant vaccine has also been developed against hepatitis B, resulting in a decline in cases. A vaccine is not yet available for hepatitis C, although there is active research in this area. Until recently Hepatitis C was routinely treated with a combination of interferon and ribavirin, which had severe side effects and low cure rates. This treatment is being replaced by nucleotides/nucleosides analogues that inhibit viral protein processing and replication enzymes. The large numbers of hepatitis B cases in the world are due to sexual transmission and mother-to-child transfer. The sharing of needles when using recreational drugs, blood transfusions, and unsanitary tattoo parlors—all these spread hepatitis C. All three viruses infect millions of people worldwide.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reuben, A. (2002). The thin red line. Hepatology, 36(3), 770–773.
Zuckerman, A.J. (1979): The history of viral hepatitis. London: Academic Press.
Dooley, D.P. (2005). History of U.S. military contributions to the study of viral hepatitis. Military Medicine , 170(4 Suppl), 71–76.
Wheeler, C., Vogt, T. M., Armstrong, G. L., Vaughan, G., Weltman, A., Nainan, O. V., et al. (2005). An outbreak of hepatitis A associated with green onions. New England Journal of Medicine, 353(9), 890–897.
Feng, Z., Lemon, S.M. (2013). Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitis. Trends Microbiology.
Blumberg, B. S., Alter, H. J., & Visnich, S. (1965). A “new” antigen in leukemia sera. JAMA, 191, 541–546.
Blumberg, B. S., Friedlaender, J. S., Woodside, A., Sutnick, A. I., & London, W. T. (1969). Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proceedings of the National Academy of Sciences USA, 62(4), 1108–1115.
Blumberg, B. S., Sutnick, A. I., & London, W. T. (1968). Hepatitis and leukemia: their relation to Australia antigen. Bulletin of the New York Academy of Medicine, 44(12), 1566–1586.
Okochi, K., & Murakami, S. (1968). Observations on Australia antigen in Japanese. Vox Sanguinis, 15(5), 374–385.
Prince, A. M. (1968). An antigen detected in the blood during the incubation period of serum hepatitis. Proceedings of the National Academy of Sciences USA, 60(3), 814–821.
Dane, D. S., Cameron, C. H., & Briggs, M. (1970). Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet, 1(7649), 695–698.
Summers, J., O’Connell, A., & Millman, I. (1975). Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proceedings of the National Academy of Sciences USA, 72(11), 4597–4601.
Robinson, W. S., & Lutwick, L. I. (1976). The virus of hepatitis, type B. (second of two parts). New England Journal of Medicine, 295(22), 1232–1236.
Robinson, W. S., & Lutwick, L. I. (1976). The virus of hepatitis, type B (first of two parts). New England Journal of Medicine, 295(21), 1168–1175.
van Zonneveld, M., Honkoop, P., Hansen, B. E., Niesters, H. G., Darwish Murad, S., de Man, R. A., et al. (2004). Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology, 39(3), 804–810.
Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244(4902), 359–362.
Krawczynski, K., & Bradley, D. W. (1989). Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. Journal of Infectious Diseases, 159(6), 1042–1049.
Kubo, Y., Takeuchi, K., Boonmar, S., Katayama, T., Choo, Q. L., Kuo, G., et al. (1989). A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Research, 17(24), 10367–10372.
Houghton, M. (2009). Discovery of the hepatitis C virus. Liver international: official journal of the International Association for the Study of the Liver, 29(Suppl 1), 82–88.
Barnes, E., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., Meyer, J., Huddart, R., Smith, K., Townsend, R et al. (2012). Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Science Translational Medicine, 4(115), 115ra111.
Howell, C. D., Dowling, T. C., Paul, M., Wahed, A. S., Terrault, N. A., Taylor, M., et al. (2008). Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 6(5), 575–583.
Conjeevaram, H. S., Fried, M. W., Jeffers, L. J., Terrault, N. A., Wiley-Lucas, T. E., Afdhal, N., et al. (2006). Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology, 131(2), 470–477.
Gane, E. J., Stedman, C. A., Hyland, R. H., Ding, X., Svarovskaia, E., Symonds, W. T., et al. (2013). Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. New England Journal of Medicine, 368(1), 34–44.
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., et al. (2009). Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature, 461(7262), 399–401.
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’Huigin, C., et al. (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature, 461(7265), 798–801.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Taylor, M.W. (2014). Hepatitis. In: Viruses and Man: A History of Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-07758-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-07758-1_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07757-4
Online ISBN: 978-3-319-07758-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)